| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Mar 17, 2016 | Option/RSU Exercise | $9.97 | 8,650 | 86,241 | 83,062 | Mar 17, 2016, 07:56 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Mar 17, 2016 | Sale | $96.70 | 6,400 | 618,880 | 76,662 | Mar 17, 2016, 07:56 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Feb 15, 2016 | Tax Payment (Shares) | $85.97 | 1,642 | 141,163 | 76,662 | Feb 16, 2016, 07:34 PM | |
| RTTR | RITTER PHARMACEUTICALS INC | Matthew W. Foehr | Director | Jan 08, 2016 | Buy | $1.64 | 13,000 | 21,320 | 17,000 | Jan 11, 2016, 04:40 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Jun 26, 2015 | Option/RSU Exercise | $9.97 | 12,500 | 124,625 | 82,628 | Jun 30, 2015, 05:39 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Jun 26, 2015 | Sale | $100.97 | 12,500 | 1,262,125 | 70,128 | Jun 30, 2015, 05:39 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Jun 29, 2015 | Option/RSU Exercise | $9.97 | 2,500 | 24,925 | 72,628 | Jun 30, 2015, 05:39 PM | |
| RTTR | RITTER PHARMACEUTICALS INC | Matthew W. Foehr | Director | Jun 24, 2015 | Buy | $5.00 | 4,000 | 20,000 | 4,000 | Jun 25, 2015, 08:56 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Jun 22, 2015 | Option/RSU Exercise | $9.97 | 25,046 | 249,709 | 91,174 | Jun 24, 2015, 06:52 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | President and COO | Jun 22, 2015 | Sale | $96.45 | 23,046 | 2,222,815 | 86,628 | Jun 24, 2015, 06:52 PM | |
| VKTX | Viking Therapeutics, Inc. | Matthew W. Foehr | Director | May 04, 2015 | Buy | $8.00 | 6,250 | 50,000 | 6,250 | May 05, 2015, 01:47 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 31, 2014 | Buy | $45.23 | 46 | 2,081 | 55,016 | Jan 05, 2015, 07:46 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Oct 13, 2014 | Option/RSU Exercise | $9.97 | 1,000 | 9,970 | 54,970 | Oct 14, 2014, 01:48 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Oct 10, 2014 | Buy | $44.91 | 85 | 3,817 | 53,970 | Oct 14, 2014, 01:48 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Jun 30, 2014 | Buy | $43.79 | 428 | 18,743 | 53,885 | Jul 01, 2014, 12:16 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Feb 14, 2014 | Option/RSU Exercise | $9.97 | 25,944 | 258,662 | 75,957 | Feb 14, 2014, 08:00 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Feb 14, 2014 | Sale | $79.54 | 22,500 | 1,789,650 | 53,457 | Feb 14, 2014, 08:00 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 31, 2013 | Buy | $33.92 | 84 | 2,849 | 45,013 | Jan 02, 2014, 04:48 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 12, 2013 | Option/RSU Exercise | $9.97 | 6,000 | 59,820 | 50,929 | Dec 13, 2013, 06:46 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 12, 2013 | Sale | $53.40 | 6,000 | 320,400 | 44,929 | Dec 13, 2013, 06:46 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Jun 28, 2013 | Buy | $17.36 | 1,059 | 18,384 | 44,929 | Jul 01, 2013, 03:27 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 05, 2012 | Buy | $17.99 | 370 | 6,656 | 37,870 | Dec 05, 2012, 04:53 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Jun 29, 2012 | Other Acquisition or Disposition | $10.12 | 1,250 | 12,654 | 37,500 | Jul 03, 2012, 05:46 PM | |
| LGNDD | LIGAND PHARMACEUTICALS INC | Matthew W. Foehr | EVP and COO | Dec 30, 2011 | Other Acquisition or Disposition | $10.09 | 1,250 | 12,612 | 26,250 | Jan 06, 2012, 05:20 PM |